Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


MEDTRONIC   FYE=4 (April)

Annual - Income Statement - Company Specific

Fiscal period2021202020192018201720162015201420132012
Period End Date4/30/20214/30/20204/30/20194/30/20184/30/20174/30/20164/30/20154/30/20144/30/20134/30/2012
Net Sales30,117.0028,913.0030,557.0029,953.0029,710.0028,833.0020,261.0017,005.0016,590.0016,184.00
Total Revenue30,117.0028,913.0030,557.0029,953.0029,710.0028,833.0020,261.0017,005.0016,590.0016,184.00
Cost of Products Sold10,483.009,424.009,155.009,067.009,294.009,142.006,309.004,333.004,126.003,889.00
Amortization of intangible assets1,783.001,756.001,764.001,823.001,980.001,931.00733.00349.00331.00335.00
Research and development expense2,493.002,331.002,330.002,256.002,193.002,224.001,640.001,477.001,557.001,490.00
Purchased in-process research and development charges--------------------
Selling, general and administrative expense10,148.0010,109.0010,418.0010,238.0010,018.009,469.006,904.005,847.005,698.005,623.00
Restructuring charges293.00118.00198.0030.00303.00290.00237.0078.00172.0087.00
Acquisition-related items----------283.00550.00117.00(49.00)12.00
Certain litigation charges, net118.00313.00166.0061.00300.0026.0042.00770.00----
Non-recurring charges--------------------
Special charges------------38.00(40.00)----
Gain on sale of businesses------697.00------------
Other income (expense) net(315.00)(71.00)(258.00)(535.00)(239.00)(107.00)(118.00)(181.00)----
Operating Profit4,484.004,791.006,268.006,640.005,383.005,361.003,766.003,813.00----
Interest expense------------666.00379.00151.00349.00
Interest income------------(386.00)(271.00)(237.00)(200.00)
Interest expense925.001,092.001,444.001,146.001,094.001,386.00280.00108.00151.00149.00
Special charges--------------------
Certain litigation charges----------------245.0090.00
Investment loss----------(70.00)--------
Interest income, net------181.00313.00431.00--------
Other income (expense) net336.00356.00373.00----------(108.00)(364.00)
Earnings before income taxes3,895.004,055.005,197.005,675.004,602.004,336.003,486.003,705.004,251.004,145.00
Provision for income taxes265.00(751.00)547.002,580.00578.00798.00811.00640.00784.00730.00
Current tax expense: U.S287.00151.00579.002,899.00614.00440.001,128.00532.00509.00664.00
Current tax expense: International439.00375.00406.00796.00840.00835.00502.00248.00219.00231.00
Deferred tax expense ( U.S(625.00)(138.00)(310.00)45.00(399.00)(67.00)(705.00)(175.00)46.00(138.00)
Deferred tax expense ( International165.00(1,139.00)(128.00)(1,160.00)(477.00)(410.00)(114.00)35.0010.00(27.00)
Tax expense recorded directly in shareholders" equity--------------------
Income (loss) from Continuing Operations------------------3,415.00
Earnings from discontinued operations--------------------
Discontinued operations- Physio-Control divestiture-related costs------------------(34.00)
Discontinued operations- Gain on sale of Physio-Control------------------204.00
Discontinued operations- Earnings from operations of Physio-Control------------------32.00
Net income3,630.004,806.004,650.003,095.004,024.003,538.002,675.00------
Net income (loss) attributable to noncontrolling interests24.0017.0019.00(9.00)(4.00)----------
Net earnings allocable to Common Units3,606.004,789.004,631.003,104.004,028.003,538.002,675.003,065.003,467.003,617.00
Earnings from continuing operations (Basic)------------------3.24
EPS (BASIC): Earnings from discontinued operations--------------------
Net Earnings Per Share (Basic)2.683.573.442.292.922.512.443.063.403.43
Earnings from continuing operations (Diluted)--------------------
EPS (DILUTED): Earnings from discontinued operations--------------------
Net Earnings Per Share (Diluted)2.663.543.412.272.892.482.413.023.373.41
Weighted Average Shares Outstanding (Basic)1,344.901,340.701,346.401,356.701,378.901,409.601,095.501,002.101,019.301,053.90
Weighted Average Shares Outstanding (Diluted)1,354.001,351.101,357.501,368.201,391.401,425.901,109.001,013.601,027.501,059.90